A Study to Learn How Safe the Study Treatment Elinzanetant is and How it Moves Into, Through and Out of the Body When Given as Single Increasing Doses That Are Higher Than Normally Used Compared to Placebo and Moxifloxacin in Healthy Participants

Clinical trial NCT05481528 · COMPLETED

Trial details

NCT number: NCT05481528
Sponsor: Bayer
Status: COMPLETED
Phase: Phase 1
Study type: INTERVENTIONAL

Vasomotor Symptoms as a Sex Hormone-dependent Disorder in Women and Men Hot Flashes Healthy Volunteers

Start date: 2022-08-19
Primary completion: 2023-02-07
Enrollment: 51

View on ClinicalTrials.gov

Track trials programmatically

Sponsors, conditions and status changes through the Atlas API.